Lennox International price target raised to $592 from $549 at JPMorgan

Lennox International (LII) reported stronger-than-expected Q2 2025 results, with adjusted EPS of $7.82 and revenue of $1.5 billion, leading to a raised full-year guidance. While Oppenheimer and Mizuho responded by increasing price targets to $730 and $650 respectively, JPMorgan, despite raising its target to $592, maintained an Underweight rating due to concerns over weakening residential volume trends, declining sell-through rates, and challenging year-over-year comparisons as prior tailwinds normalize.

Analysis

Lennox International (LII) delivered a strong second-quarter 2025 performance, with adjusted EPS of $7.82 and revenue of $1.5 billion surpassing analyst forecasts and prompting management to raise full-year guidance. This beat was attributed to improved margins in the Home Comfort Solutions segment and increased volume in the Building Climate Solutions division, supporting the company's robust 24.28% return on assets. The positive results led Oppenheimer and Mizuho to raise their price targets to $730 and $650, respectively. However, a significant divergence in analyst sentiment exists, as JPMorgan, while lifting its target to $592, maintained an Underweight rating. JPMorgan's caution is rooted in forward-looking risks, specifically citing seasonally weak residential volume trends and declining year-over-year sell-through rates. The firm warns that Lennox is entering a period of its "toughest comps in many years" as tailwinds from prior market share gains and customer pre-buying are expected to normalize. With the stock trading near its 52-week high at $660.82 and technical signals indicating overbought conditions, the market is weighing demonstrated operational strength against tangible headwinds on the horizon.

Key Decisions for Investors

• Investors should weigh the company's proven execution, evidenced by the strong Q2 earnings beat and raised guidance, against the significant forward-looking risks identified by JPMorgan concerning residential demand and difficult year-over-year comparisons.
• Given the stock is trading near its 52-week high and technicals suggest overbought conditions, it may be prudent to monitor for any signs of slowing residential sell-through rates in upcoming quarters, which would validate the cautious outlook.
• Consider the wide dispersion in analyst price targets, from JPMorgan's $592 to Oppenheimer's $730, as an indicator of uncertainty, suggesting that locking in some profits or using options to hedge positions could be a reasonable strategy.